Sildenafil Citrate Tablet, Film Coated
Product Images NDC 60290-079

This is a product description for Sildenafil tablets. Each tablet contains Sildenafil citrate USP equivalent to 100 mg of Sildenafil. The tablets should be stored at 25°C (77°F) with permitted excursions between 15-30°C (59-86°F). They are dispensed in child-resistant, tight containers. For dosage and usage information, refer to the accompanying prescribing information and Medication Guide available at the provided website. The product is distributed by Umedica Laboratories USA Inc. from Parsippany, NJ, and is manufactured by Umedica Laboratories Pvt. Ltd. in India.*

This text provides information about Sildenafil tablets containing Sildenafil citrate USP. The tablets are to be stored at 25°C but can tolerate excursions within 15-30°C. They should be dispensed in tight, child-resistant containers. The dosage and usage details are available in the accompanying prescribing information. The tablets are manufactured in India and distributed in the USA. For further details, a medication guide is accessible online. The package contains 1000 tablets.*

This text contains information about Sildenafil tablets, which contain 25mg of Sildenafil citrate. The recommended storage temperature is at 25°C (77°F), with permissible excursions between 15-30°C (59-86°F). The tablets should be dispensed in tight containers and are child-resistant. For dosage and usage instructions, refer to the accompanying prescribing information. It also mentions a Medication Guide available at a specific URL. The tablet packaging is associated with the manufacturer Umedica Laboratories Pvt. Ltd. from India and distributed by Umedica Laboratories USA Inc. from Parsippany, NJ. The tablet package includes 30 tablets with a GTIN code for identification purposes.*

This is a description of a medication containing Sildenafil citrate in 50 mg tablets. The manufacturing license number is G/25/491, and it is manufactured by Umedica Laboratories Pvt. Ltd. in Vapi, Gujarat, India. The tablets are stored at temperatures between 15-30°C (59-86°F), dispensed in tight containers, and are child-resistant. The dosage and usage instructions are available in the accompanying prescribing information and a Medication Guide can be found at the website provided. This product is distributed by Umedica Laboratories USA Inc. in Parsippany, NJ, 07054.*

This text provides information about sildenafil tablets containing 50 mg of sildenafil citrate, stored at 25°C, dispensed in child-resistant packages, and with dosage details available in the prescribing information. The package includes a medication guide, and the tablets are manufactured in India by Umedica Laboratories Pvt. Ltd. and distributed in the USA by Umedica Laboratories USA Inc. The text also includes manufacturing and distribution details, such as Mfg. Lic. No., Rev date, NDC code, and a GTIN code. *

This text provides data on the Change in Systolic Blood Pressure (SBP) in millimeters of mercury (mmHG) over time postdose for two different treatment groups: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The chart includes time points from 0 to 7 hours postdose for comparison of the treatments' effects on SBP.*

This text appears to be a table showing different treatments with doxazosin and placebo, along with sildenafil 50 mg. It also includes time points post-dose.*

This text provides information on the effect of sildenafil citrate on the maintenance of erection based on baseline scores. It seems to compare the impact of sildenafil citrate with a placebo on patient outcomes at an endpoint. The data includes percentage breakdowns of patients at endpoint according to various baseline scores.*

This text appears to be a statistical analysis of a treatment group involving Sildenafil citrate at different dosages (25mg and 100mg) with a total sample size of 594 participants. The analysis shows significant improvement in the treatment group compared to the control group, with an overall treatment effect of p<0.0001.*